Commonly reported side effects of albiglutide include: injection site reaction, diarrhea, and nausea. Other side effects include: vomiting.  See below for a comprehensive list of adverse effects.
Applies to albiglutide: subcutaneous powder for solution
In addition to its needed effects, some unwanted effects may be caused by albiglutide. In the event that any of these side effects do occur, they may require medical attention.
You should check with your doctor immediately if any of these side effects occur when taking albiglutide:
Some of the side effects that can occur with albiglutide may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:


Applies to albiglutide: subcutaneous powder for injection
Very common (10% or more): Diarrhea (13.1%), nausea (11.1%), Common (1% to 10%): Vomiting, gastroesophageal reflux disease, dyspepsia, constipation Uncommon (0.1% to 1%): Appendicitis, acute pancreatitis, intestinal obstruction[Ref]
The incidence of pancreatitis (adjudicated as likely to be related to therapy) in clinical trials was 0.3% compared with 0% for placebo and 0.1% for comparators (e.g., liraglutide, pioglitazone, glimepiride, sitagliptin, and insulin glargine) with or without background antidiabetic therapy (e.g.  metformin) Gastrointestinal events occurred more frequently with this drug compared to comparators (38% versus 32%).  Diarrhea (13% vs 9%), nausea (12% vs 11%), vomiting (5% vs 4%), and constipation (5% vs 4%) were the most commonly reported , and the majority of events occurred within the first 6 months.[Ref]
Very common (10% or more): Positive test for anti-albiglutide antibodies[Ref]
Very common (10% or more): Injection site reaction (up to 15%)Common (1% to 10%): Injection site hematoma, erythema, rash, and/or pruritusUncommon (0.1% to 1%): Injection site hypersensitivity and/or hemorrhage[Ref]
Very common (10% or more): Hypoglycemia (when used in combination with insulin or sulfonylurea) Common (1% to 10%): Hypoglycemia (when used as monotherapy in combination with metformin or pioglitazone)[Ref]
Very common (10% or more): Back pain (6.7%), arthralgia (6.6%)[Ref]
Very common (10% or more): Influenza (5.2%)[Ref]
Very common (10% or more): Upper respiratory tract infection (14.2%), cough (6.9%), sinusitis (6.2%)Common (1% to 10%): Pneumonia[Ref]
Common (1% to 10%): Atrial fibrillationUncommon (0.1% to 1%): Atrial flutter[Ref]
Common (1% to 10%): Increased ALT, gamma glutamyltransferase[Ref]
Frequency not reported: Pruritus, rash, dyspnea[Ref]
Frequency not reported: Risk of Thyroid C-cell Tumors[Ref]
Medullary thyroid cancer (MTC) was diagnosed in 1 patient receiving this drug and 1 patient receiving placebo across 8 phase 3 clinical trials.  Both of these patients had markedly elevated serum calcitonin levels at baseline.[Ref]
Frequency not reported: Renal impairment[Ref]
1. "Product Information. Tanzeum (albiglutide)." GlaxoSmithKline, Research Triangle Park, NC. 
2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
Not all side effects for albiglutide may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Bloating
chills or fever
darkened urine
fast heartbeat
loss of appetite
nausea, vomiting, or indigestion
pains in the stomach, side, or abdomen, possibly radiating to the back


Anxiety, irritability, or mood changes
blurred vision
cold sweats
confusion
difficulty with breathing or swallowing
dizziness
headache
increased hunger
shakiness
skin itching, rash, or redness
slurred speech
swelling of the face, throat, or tongue
unusual tiredness or weakness


Body aches or pain
cough
diarrhea
ear congestion
loss of voice
muscle pain or stiffness
pain in the joints
pain or tenderness around the eyes and cheekbones
skin reactions, warmth, or redness at the injection site
sneezing
stuffy or runny nose

